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Tiffany K Gill1*, Catherine L Hill2,3, E Michael Shanahan4,5, Anne W Taylor6, Sarah L Appleton3, Janet F Grant6,
Zumin Shi1, Eleonora Dal Grande6, Kay Price7 and Robert J Adams3Abstract
Background: Levels of vitamin D in the population have come under increasing scrutiny, however there are only a
few studies in Australia which measure levels in the general population. The aim of this study was to measure the
levels of vitamin D within a large population cohort and examine the association with seasons and selected
demographic and health risk factors.
Methods: A longitudinal cohort study of 2413 participants in the northwest suburbs of Adelaide, South Australia
conducted between 2008 and 2010 was used to examine serum levels of 25-hydroxy vitamin D (25(OH)D) in
relation to demographic characteristics (age, sex, income, education and country of birth), seasons, the use of
vitamin D supplements and selected health risk factors (physical activity, body mass index and smoking). Both
unadjusted and adjusted mean levels of serum 25(OH)D were examined, as were the factors associated with the
unadjusted and adjusted prevalence of serum 25(OH)D levels below 50 and 75 nmol/L.
Results: Overall, the mean level of serum 25(OH)D was 69.2 nmol/L with 22.7% of the population having a serum
25(OH)D level below 50 nmol/L, the level which is generally recognised as vitamin D deficiency. There were
significantly higher levels of 25(OH)D among males compared to females (t = 4.65, p < 0.001). Higher levels of 25
(OH)D were also measured in summer and autumn compared with winter and spring. Generally, mean levels of 25
(OH)D were lower in those classified as obese. Smokers and those undertaking no or less than 150 minutes/week of
physical activity also had lower levels of serum vitamin D. Obesity (as classified by body mass index), season and
undertaking an insufficient level of physical activity to obtain a health benefit were significantly associated with the
prevalence of vitamin D deficiency.
Conclusions: Vitamin D deficiency is prevalent in South Australia, affecting almost one quarter of the population
and levels are related to activity, obesity and season even when adjusted for confounding factors. Improved
methods of addressing vitamin D levels in population are required.
Keywords: Vitamin D, Population, Cohort study, Risk factors, Demographic factorsBackground
Vitamin D plays an important role in the formation of
bone and low levels of vitamin D have been associated
with the development of rickets and osteoporosis [1,2].
There is also evidence to suggest that vitamin D defi-
ciency is associated with mortality [3] and a wide range
of other conditions including type 2 diabetes [4], gesta-
tional diabetes [5], cardiovascular disease [6], rheuma-
toid arthritis [7], chronic obstructive pulmonary disease
[8], type 1 diabetes, some cancers (for example, colorec-
tal, prostate, breast) and multiple sclerosis [1], muscle* Correspondence: tiffany.gill@adelaide.edu.au
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unless otherwise stated.weakness [1] as well as chronic kidney disease [9], schi-
zophrenia and depression [1]. However, these studies are
often cross sectional in nature and undertaken under
varying conditions, making comparisons difficult and
limiting the strength of the evidence.
Generally, the primary source of vitamin D is from ultra-
violet exposure via sunlight or from food or supplements
[1]. Vitamin D is then converted to 25-hydroxyvitamin D in
the liver. Serum level of 25-hydroxyvitamin D (25(OH)D)
provides an indication of overall vitamin D status [1].
Levels of vitamin D vary according to season [1] and it is
acknowledged that vitamin D deficiency is generally high
within the population and varies according to the popula-
tion under examination [1]. Various cutoffs have also been. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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insufficiency as 25-50 nmol/L, and sufficiency >50 nmol/L
by Lau et al. [5]. Deficient has also been defined
as <27.5 nmol/L, insufficient as 27.5-49.9 nmol/L and sub-
optimal as 50- < 75 nmol/L by Green-Finstone et al. [10].
In South Australia (SA), the optimal range defined by SA
Pathology is 60-160 nmol/L derived from levels required
to suppress parathyroid hormone and bone turnover
markers [11]. However, vitamin D deficiency has more
recently been considered to be less than 50 nmol/L [1,12].
Vitamin D levels have been measured in association
with specific disease groups and mortality [1-9], however
there are fewer studies which examine the prevalence of
vitamin D deficiency at a population level using large
samples. Internationally, research conducted in Canada,
the United States, Great Britain, New Zealand and
Denmark [10,13-17] have examined vitamin D deficiency
in population-based studies, with the prevalence of vita-
min D levels < 50 nmol/L ranging between 18% and 52%,
although different cutoff values for vitamin D deficiency
are reported in some of these studies. International com-
parisons can also be difficult due to differences in factors
such as testing methods, latitudes, season of testing, age
range tested and population composition. Thus specific
Australian studies also have relevance.
A study conducted in south-east Queensland at the end
of winter among 126 adults aged 18–87 years living in the
community identified that 10.2% of the participants had
serum 25(OH)D levels below 25 nmol/l, which was con-
sidered to be deficient. A further 32.3% had a level of
between 25 nmol/l and 50 nmol/l, which was defined
as insufficient [18]. In Tasmania, among a community
control group of 272 adults, 8.8% had 25(OH)D levels
up to 25 nmol/L, with 14.5% having 25(OH)D levels
26-40 nmol/L and a further 25.3% between 41-50 nmol/L
[19]. A cross-sectional, population-based study of women
aged 20–92 years (n = 861) in Geelong, Victoria demon-
strated that 11.3% and 7.2% of the population had serum
25(OH)D levels of <28 nmol/L in winter and overall re-
spectively and 43.2% and 30.0% had levels <50 nmol/L, in
winter and overall, respectively [20]. A comparison of the
previous two studies [19,20] and another in southeast
Queensland [21] demonstrated that, among females less
than 60 years of age, the prevalence of vitamin D insuffi-
ciency <50 nmol/L was 67.3% in Tasmania, 40.5% in
Queensland and 37.4% in the Geelong area. While season
and latitude both had an impact on vitamin D levels, less
than one fifth of the variation was explained by these fac-
tors highlighting the importance of behavioural factors
[22]. The largest study has been conducted by Daly et al.
[23] and examined vitamin D levels obtained from 11,247
samples collected Australia wide. This study demonstrated
that vitamin D deficiency (<50 nmol/L) was common in
Australian adults aged 25 years and over (31%) and thatthose most at risk were women, the obese, the elderly,
those not meeting physical activity guidelines and those
with a non-European background [23]. However, the
blood used for serum 25(OH)D testing was taken at only
one time point, between May and July 2000 in SA, which
is the end of autumn and the beginning of winter. Daly
et al. [23] point out that the pooling of results obtained
from all states of Australia could be misleading and that
by testing blood that was collected in 1999/2000, there
may have been changes in vitamin D status since that
time.
Adelaide, the capital of South Australia lies at a
latitude 36 degrees S. Thus, while it is not below the 42
degrees of latitude which has been shown to be the level
where cutaneous production of vitamin D does not
occur [24], vitamin D will certainly be synthesized at
varying rates, throughout the year, depending on the sea-
son and will be in contrast to previous Australian studies
undertaken in different locations. Work undertaken by
Morris et al. [25] as early as 1984 demonstrated a signifi-
cant seasonal variation in 25(OH)D levels in SA, tested
as part of routine assays. However, to date there have
been no large scale epidemiological studies to examine
vitamin D levels specifically in this state. The advantages
of this study are that it is solely focused on the popula-
tion of Adelaide and involves a population cohort of
over 2000 participants. Vitamin D levels were deter-
mined from samples taken across all seasons and as this
is a longitudinal cohort study, the potential exists to
examine levels of 25(OH)D in conjunction with a wide
range of demographic, chronic disease, risk and social
factors which have been collected over time. Information
related to vitamin D supplementation is also available.
This paper reports the level of vitamin D deficiency
and examines these values in conjunction with various
demographic (age, sex, income, education) and health
risk factors (body mass index, physical activity and
smoking), season and the use of vitamin D supplements.Methods
This paper reports data collected as part of Stage 3 of the
North West Adelaide Health Study (NWAHS). The
NWAHS is a representative longitudinal study of 4056 ran-
domly selected adults aged 18 years and over at the time of
recruitment from the north-west region of Adelaide, the
capital of SA. The sample region represents approximately
half of the metropolitan area (population of approximately
1.3 million) and almost one-third of the population in SA
(population of approximately 1.68 million), which has the
second highest elderly population of all the Australian
states and territories. The study commenced in 1999 to
2003 and Stage 2 was conducted between 2004 and 2006.
Stage 3 was conducted between 2008 and 2010, with
Table 1 Descriptive characteristics of those who provided





Age [mean ± SD] 49.6 ± 16.2 51.5 ± 16.9
BMI [mean ± SD]* 28.6 ± 4.8 28.5 ± 6.4
Underweight (%) 0.3 1.4
Normal (%) 21.9 30.8
Overweight (%) 45.9 32.5
Obese (%) 31.8 35.3
Country of birth (%)*
Australia 72.9 73.8
Country other than Australia 27.1 25.9
Season (%)
Summer (Dec-Feb) 18.5 23.6
Autumn (Mar-May) 23.9 21.5
Winter (Jun-Aug) 29.7 29.1
Spring (Sep-Nov) 28.0 25.8
Income (%)
Up to $60,000 39.7 46.9
More than $60,000 51.8 41.7
Don’t know/not stated 8.5 11.4
Education (%)
Some schooling 25.4 40.2
Completed high school 10.4 14.7
Apprenticeship/diploma 40.3 24.4
University or higher education 20.7 18.4
Refused/not stated 3.2 2.3
Smoking status (%)
Current smoker 18.2 16.7
Ex/non smoker 80.4 82.0
Not stated 1.4 1.2
Physical activity (%)
No activity 15.1 20.5
Insufficient activity 28.4 35.0
Sufficient activity 52.9 42.1
Not stated 3.6 2.4
Vitamin D supplement (%)
Took vitamin D 2.0 6.1
Took supplements but not vitamin D 25.0 29.3
Did not take supplements/not stated 73.1 64.6
*Not stated category not reported n ≤ 10.
The weighting of data can lead to rounding discrepancies and totals
not adding.
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methodologies.
Information was obtained from a computer assisted
telephone interview (CATI), a self-completed question-
naire and a clinic assessment. Of the original cohort of
participants (n = 4056), n = 2487 completed the clinic as-
sessment in Stage 3, with n = 2710 completing the CATI
survey and n = 2638 the self-complete questionnaire.
The response rate for each assessment following com-
pletion of Stage 3 was 73.0% for the CATI survey, 71.1%
for the written questionnaire and 67.0% for the clinic
assessment.
Country of birth and smoking were determined from re-
sponses to the self-complete questionnaire. Gross annual
household income prior to tax and highest level of educa-
tion of participants were collected as part of the telephone
questionnaire. The level of physical activity was deter-
mined from descriptions of physical activity type and time
using the questions from the Active Australia survey [26].
This information was used to calculate whether respon-
dents had achieved a sufficient level of physical activity to
achieve a health benefit in the past week [26]. Sufficient
physical activity was defined as a total of 150 minutes of
walking, moderate or vigorous physical activity with vi-
gorous activity weighted by a factor of two to account for
its greater intensity [26]. Age was calculated from date of
birth and the date of attendance at the clinic assessment
and the season when blood was taken was determined
from the month of the clinic assessment. Information re-
lating to the use of vitamin D supplements within the past
12 months was asked as part of the Dietary Questionnaire
for Epidemiological Studies (DQES, Cancer Council of
Victoria), which was used in this study to assess diet and
nutrition.
Height and weight were measured with standardized
protocols. A wall mounted stadiometer measured height
to the nearest 0.5 centimetres and weight was measured
using calibrated scales to the nearest 0.1 kilograms. Body
mass index (BMI) was then calculated (weight (kg)/
height (m2)) [27].
Fasting blood samples were collected and analysed in
real time by the NATA certified laboratories of SA Patho-
logy in Adelaide. The vitamin D assay was initially mea-
sured (until April 2010) using the Enzyme Immunoassay
method and was performed on a BEST 2000 automated
ELISA system (Biokit). The interassay coefficient of vari-
ation (CV) was 5.6% for a mean of 33.3 nmol/L and 3.9%
for a mean of 112.8 nmol/L. After April 2010, the assay
was changed to an Automated Chemiluminescent assay
and performed on an iSYS Automated Immunoassay sys-
tem (IDS). The CV was 10.5% for a mean of 33.4 nmol/L,
7.0% for a mean of 80.3 nmol/L and 7.3% for a mean of
165.2 nmol/L. Overall, 90% of assays were conducted
using the first test procedure. When the assays werechanged the patient comparison gave a Passing-Bablock
regression equation of y = −1.61 + 1.07x with a bias
of −1.9 nmol/L indicating good agreement between the
two assays. Not all participants in Stage 3 were willing or
Table 2 Mean (95% CI) level of vitamin D (nmol/L), by age group, BMI categories, country of birth, season, income,
education, smoking status, activity level and vitamin D supplement status for males and females
Males Females
Variables n Unadjusted Adjusted† n Unadjusted Adjusted
Overall population 1164 72.5 (70.5-74.6) 69.1 (68.5-69.8) 1249 66.0 (64.2-67.8) 69.2 (68.5-69.9)
Age (years)
24-34 years 252 70.0 (63.9-76.2) 68.1 (66.1-70.1) 248 65.1 (59.5-70.6) 67.1 (64.7-69.5)
35-44 years 254 72.8 (67.6-78.0) 69.1 (67.7-70.4) 256 64.9 (60.6-69.2) 68.6 (67.0-70.1)
45-54 years 241 70.2 (66.7-73.7) 66.4 (65.3-67.4) 245 63.0 (59.8-66.2) 66.8 (65.7-67.9)
55-64 years 188 73.8 (70.1-77.5) 70.2 (69.1-71.2) 202 67.2 (64.0-70.4) 70.6 (69.5-71.7)
65-74 years 122 78.5 (74.1-82.9) 72.5 (71.3-73.6) 141 67.6 (63.3-71.8) 72.7 (71.5-74.0)
75 years and over 108 74.0 (69.3-78.7) 72.1 (70.7-73.4) 157 71.1 (66.4-75.7) 72.4 (70.9-73.9)
BMI*
Underweight 4 80.9 (62.2-99.7) 56.8 (52.2-61.5) 18 51.4 (32.9-69.8) 56.7 (53.1-60.2)
Normal 256 74.9 (70.9-78.9) 73.4 (72.1-74.7) 385 72.5 (68.8-76.1) 73.4 (72.2-74.7)
Overweight 534 74.7 (71.3-78.1) 70.8 (69.9-71.7) 406 66.3 (63.4-69.2) 71.4 (70.2-72.5)
Obese 370 67.8 (64.5-71.1) 64.0 (62.0-64.7) 440 60.7 (58.1-63.4) 64.0 (63.2-64.9)
Country of birth*
Australia 848 73.7 (71.2-76.2) 69.8 (69.0-70.6) 922 66.4 (64.3-68.6) 70.0 (69.2-70.9)
Other country 315 69.5 (66.1-72.9) 67.3 (66.3-68.3) 323 64.9 (61.6-68.2) 67.0 (65.9-68.2)
Season
Summer 215 84.1 (78.0-90.2) 77.1 (75.9-78.4) 295 71.3 (67.3-75.3) 76.4 (74.8-78.0)
Autumn 278 77.6 (73.7-81.4) 73.2 (72.2-74.2) 269 69.0 (65.5-72.4) 73.5 (72.5-74.5)
Winter 345 67.5 (63.5-71.4) 65.6 (64.7-66.5) 363 63.1 (59.8-66.3) 64.9 (63.9-65.8)
Spring 326 66.0 (63.4-68.6) 64.1 (63.1-65.0) 322 62.0 (58.4-65.7) 64.0 (63.1-64.9)
Income
Up to $60,000 462 74.3 (71.3-77.4) 69.6 (68.7-70.5) 586 65.5 (63.0-68.0) 69.1 (68.3-70.0)
More than $60,000 603 71.3 (68.2-74.4) 68.9 (67.9-69.8) 520 65.6 (62.6-68.7) 68.6 (67.5-69.7)
Don’t know/not stated 99 71.8 (64.8-78.7) 68.2 (65.7-70.8) 143 69.7 (64.9-74.4) 72.1 (69.4-74.8)
Education
Some schooling 296 74.1 (70.7-77.6) 69.2 (68.5-70.3) 502 67.0 (64.3-69.7) 69.9 (69.0-70.7)
Completed high school 122 73.7 (67.8-79.6) 68.9 (66.5-71.3) 184 66.8 (61.9-71.8) 70.0 (68.3-71.7)
Apprentice/diploma 469 75.1 (71.7-78.6) 70.9 (70.0-71.8) 305 63.8 (60.4-67.3) 70.3 (68.6-72.0)
University or higher education 240 66.8 (62.2-71.4) 66.6 (65.2-68.0) 230 65.9 (61.2-70.6) 66.2 (64.5-67.9)
Refused/not stated 38 60.7 (50.8-70.5) 62.7 (59.9-65.4) 28 67.6 (53.4-81.8) 64.9 (60.8-69.1)
Smoking status
Non/ex 937 73.4 (71.1-75.7) 69.7 (69.0-70.3) 1025 66.5 (64.4-68.5) 69.9 (69.1-70.6)
Current 212 69.2 (64.4-73.9) 66.5 (64.5-68.5) 209 63.5 (59.7-67.3) 66.2 (64.8-67.7)
Not stated 16 66.9 (55.3-78.5) 70.7 (67.5-73.8) 15 70.8 (59.2-82.5) 66.9 (61.8-72.0)
Physical activity
No activity 176 71.5 (65.3-77.6) 65.1 (63.6-66.7) 256 60.2 (56.3-64.1) 64.6 (63.4-65.8)
Insufficient activity 330 69.7 (66.2-73.2) 66.4 (65.5-67.4) 437 64.6 (61.1-68.0) 67.0 (65.9-68.1)
Sufficient activity 616 75.0 (72.1-77.8) 72.0 (71.1-72.8) 526 69.8 (67.5-72.2) 73.4 (72.3-74.4)
Not stated 42 63.8 (54.5-73.0) 65.1 (61.4-68.9) 30 69.9 (57.0-82.7) 67.9 (64.4-71.5)
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Table 2 Mean (95% CI) level of vitamin D (nmol/L), by age group, BMI categories, country of birth, season, income,
education, smoking status, activity level and vitamin D supplement status for males and females (Continued)
Vitamin D supplement
Took vitamin D 23 82.0 (72.3-91.6) 77.3 (74.2-80.3) 76 77.1 (71.4-82.8) 78.5 (76.7-80.3)
Took supplements but not vitamin D 290 72.0 (68.2-75.8) 67.4 (66.2-68.7) 366 63.0 (60.3-65.8) 66.7 (65.6-67.7)
Did not take supplements/not stated 851 72.5 (70.0-75.0) 69.4 (68.7-70.2) 808 66.3 (63.9-68.7) 69.5 (68.6-70.4)
*Not stated category not reported n ≤ 10. The weighting of data can lead to rounding discrepancies and totals not adding.
†Adjusted for age group, BMI categories, country of birth, season, income, education, smoking status, activity level, vitamin D supplement status.
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on those respondents who provided blood for testing and
for whom a vitamin D test was able to be performed
(n = 2413).
In Stage 1, data were weighted by region (western and
northern health regions), age group, sex and probability
of selection in the household to the Australian Bureau of
Statistics 1999 Estimated Resident Population and the
2001 Census data. Stage 3 was reweighted using the
2009 Estimated Resident Population, incorporating par-
ticipation in the three components, whilst retaining the
original weight from Stage 1 in the calculation. All ana-
lyses conducted in this paper are weighted to the popu-
lation of the northern and western suburbs of Adelaide.
Ethics approval for the study was obtained from the
Human Research Ethics committee of The Queen
Elizabeth Hospital, Adelaide, South Australia and all
participants provided informed consent.
Statistical analyses were conducted using SPSS Version
19 (IBM SPSS Statistics, New York, NY, USA) and Stata
version 12 (StataCorp, College Station, TX, USA). Descrip-
tive characteristics (means and proportions) are presented
for all participants as are the proportions of participants
with various levels of 25(OH)D. T-tests and chi square
tests were used to determine significant differences in vita-
min D levels between males and females. ANOVA deter-
mined significant differences in the mean age of those who
did and did not take supplements. The unadjusted mean
values of serum 25(OH)D were determined by age group,
BMI, country of birth, season, income, education, smokingTable 3 Proportion of males, females and overall population
Males
n % (95% CI)
Less than 25 nmol/L* 5 0.4 (0.2-1.0)
Less than 30 nmol/L* 18 1.6 (1.0-2.5)
Less than 40 nmol/L* 74 6.4 (4.9-8.3)
Less than 50 nmol/L* 215 18.5 (15.5-21.9)
Less than 60 nmol/L* 380 32.6 (28.9-36.6)
Less than 75 nmol/L* 692 59.5 (55.3-63.5)
Less than 100 nmol/L 1005 86.4 (83.1-89.0) 1
The weighting of data can lead to rounding discrepancies and totals not adding.
*Chi square test indicates significant difference in prevalence in each category betwstatus, physical activity and taking vitamin D supplements.
The mean levels of 25(OH)D were then adjusted for the
above variables, all of which may act as confounders. The
prevalence of males and females with vitamin D levels less
than 50 nmol/L and less than 75 nmol/L was determined
by age group, BMI, country of birth season, income, edu-
cation, smoking status, physical activity and taking vitamin
D supplements and multivariable logistic regression ana-
lysis was undertaken with all of the above variables in the
model to determine independent predictors of vitamin D
deficiency (serum 25(OH)D < 50 nmol/L) and vitamin D
levels < 75 nmol/L.
Results
Overall there were no significant differences in the pro-
portion of males and females and within each age group
for those who did, and did not, provide a blood sample
for serum 25(OH)D testing. The mean age of those who
provided a vitamin D sample was 50.6 years (SD 16.6,
range 24–95). Overall, the mean level of serum 25(OH)
D was 69.2 nmol/L (n = 2413, SD 26.4, range 14–286).
Levels ≤ 220 nmol/L can be considered within the nor-
mal physiological range [28], thus within this cohort
three participants may have toxic levels of serum 25
(OH)D (data not shown). There was a significant diffe-
rence between males (n = 1164, mean 72.5, SD 26.5) and
females (n = 1249, mean 66.0, SD 25.9) in serum 25(OH)
D (t = 4.65, p < 0.001).Of those who had serum 25(OH)D
levels measured, only 4.1% reported that they took
vitamin D supplements with the mean age of thosebelow various cut off values for Vitamin D
Females Overall
n % (95% CI) n % (95% CI)
16 1.3 (0.8-2.2) 21 0.9 (0.6-1.4)
43 3.5 (2.4-4.9) 61 2.5 (1.9-3.4)
182 14.6 (12.1-17.5) 256 10.6 (9.1-12.4)
334 26.8 (23.6-30.2) 549 22.7 (20.5-25.1)
549 44.0 (40.2-47.8) 929 38.5 (35.8-41.3)
861 68.9 (65.2-72.3) 1553 64.3 (61.6-67.0)
121 89.8 (87.4-91.7) 2127 88.1 (86.2-89.8)
een males and females p < 0.05.
Table 4 Prevalence of serum 25(OH)D levels < 50 and <75 nmol/l, and adjusted odds ratios (95% CI) in males
<50 nmol/l <75 nmol/l
Variables n Prevalence Odds ratio† n Prevalence Odds ratio†
Overall 215 18.5 692 59.5
Age (years)
24-34 years 54 21.4 1.00 147 58.5 1.00
35-44 years 41 16.0 0.73 (0.32-1.68) 157 61.8 1.20 (0.59-2.47)
45-54 years 45 18.8 0.75 (0.34-1.64) 155 64.5 1.27 (0.62-2.59)
55-64 years 33 17.6 0.58 (0.25-1.35) 110 58.3 0.89 (0.43-1.82)
65-74 years 16 12.8 0.37 (0.14-0.95) 64 52.6 0.80 (0.38-1.68)
75 years and over 26 24.4 0.85 (0.32-2.27) 59 54.8 0.90 (0.41-1.99)
BMI*
Underweight/normal 40 15.3 1.00 141 54.2 1.00
Overweight 84 15.7 1.12 (0.60-2.12) 304 56.9 1.17 (0.74-1.83)
Obese 91 24.6 2.21 (1.19-4.11) 247 66.8 1.72 (1.05-2.80)
Country of birth*
Australia 135 16.0 1.00 496 58.4 1.00
Other country 79 25.0 1.93 (1.22-3.05) 196 62.2 1.38 (0.95-2.01)
Season
Summer 18 8.2 1.00 96 44.4 1.00
Autumn 32 11.7 1.75 (0.62-4.91) 136 49.0 1.37 (0.78-2.39)
Winter 90 26.0 4.55 (1.66-12.44) 225 65.2 2.76 (1.52-5.02)
Spring 75 23.1 4.08 (1.51-10.98) 235 72.3 3.90 (2.23-6.80)
Income
Up to $60,000 96 20.8 1.00 261 56.4 1.00
More than $60,000 99 16.4 0.75 (0.43-1.30) 382 63.3 1.22 (0.81-1.84)
Don’t know/not stated 20 20.2 0.60 (0.23-1.57) 50 50.5 0.56 (0.23-1.37)
Education
Some schooling 52 17.7 1.00 168 56.9 1.00
Completed high school 12 10.0 0.42 (0.16-1.08) 77 63.4 1.14 (0.61-2.14)
Apprentice/diploma 77 16.4 1.03 (0.63-1.70) 257 54.7 0.89 (0.60-1.33)
University or higher education 61 25.3 2.27 (1.17-4.37) 165 68.5 1.93 (1.03-3.62)
Refused/not stated 13 34.2 8.96 (1.21-66.45) 25 67.4 39.21 (3.09-496.76)
Smoking status
Non/ex 167 17.9 1.00 554 59.1 1.00
Current 46 21.5 1.35 (0.76-2.39) 131 61.8 1.38 (0.82-2.33)
Not stated 2 13.1 0.93 (0.17-4.98) 7 46.9 0.92 (0.22-3.87)
Physical activity
No activity 39 22.4 1.00 113 64.0 1.00
Insufficient activity 69 21.0 0.95 (0.55-1.63) 221 67.0 1.06 (0.66-1.71)
Sufficient activity 93 15.1 0.53 (0.31-0.90) 333 54.1 0.59 (0.38-0.91)
Not stated 13 30.6 0.20 (0.04-1.14) 25 60.4 0.05 (0.01-0.43)
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Table 4 Prevalence of serum 25(OH)D levels < 50 and <75 nmol/l, and adjusted odds ratios (95% CI) in males
(Continued)
Vitamin D supplement
Took vitamin D 2 10.7 1.00 10 42.9 1.00
Took supplements but not vitamin D 43 14.8 2.13 (0.49-9.20) 182 62.7 2.88 (1.11-7.51)
Did not take supplements/not stated 170 19.9 2.93 (0.70-12.33) 500 58.8 2.17 (0.87-5.42)
*Not stated category not reported n ≤ 10. The weighting of data can lead to rounding discrepancies and totals not adding.
†Adjusted for age group, BMI categories, country of birth, season, income, education, smoking status, activity level, vitamin D supplement status.
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http://www.biomedcentral.com/1471-2458/14/1001respondents significantly higher (59.23 years) compared
to those who did not respond or take supplements at all
(50.18 years) or who took supplements but did not take
vitamin D (50.38 years; F = 14.21, p < 0001). Overall 9.0%
of those aged 75 years and over took vitamin D supple-
ments compared to 0.9% of those aged 24 to 34 years,
with the proportion increasing across all age groups.
The characteristics of those who provided a sample for
vitamin D testing are presented in Table 1. Participants
were primarily born in Australia, with approximately a
third of both males and females classified as obese. A
higher proportion of males were current smokers and a
lower proportion of females undertook a sufficient level
(≥150 minutes per week) of physical activity.
Due to the significant difference in mean serum levels
between males and females, the analysis of each sex was
undertaken separately. The unadjusted and adjusted mean
serum levels of 25(OH)D for age group, BMI, country of
birth, season, income, education level, smoking status,
physical activity level and whether or not vitamin D
supplements were taken are presented in Table 2. Both
adjusted and unadjusted mean levels of serum 25(OH)D
were higher in both summer (December, January, February)
and autumn (March through May). Those with lower
levels of education (a trade certificate or diploma) also
had higher levels of 25(OH)D as did ex-smokers com-
pared to current smokers. For both males and females,
those who undertook no activity had lower mean vitamin
D levels compared to those who had a sufficient level of
activity (150 minutes or more of walking, moderate or
vigorous activity during the week).
The proportion of males, females and the population
overall at various cutoff levels of serum 25(OH)D is shown
in Table 3. Overall, 0.9% of the population had serum 25
(OH)D below 25 nmol/L and 22.7% had levels below
50 nmol/L. When considered in the context of South
Australian reported levels, 38.5% had serum levels below
60 nmol/L with 60.9% of participants in the optimal range
of 60-160 nmol/L. There was a significantly higher pro-
portion of females compared to males within each cate-
gory (p < 0.05) except for those aged 75 years and over
(p = 0.06).
The prevalence of serum 25(OH)D levels below 50
and 75 nmol/L for males and females are shown inTables 4 and 5 respectively. For males, those with vita-
min D deficiency were more likely to be obese, not born
in Australia and have a university level of education and
those with levels < 75 nmol/L were more likely to be
obese and had higher levels of education. Females with
vitamin D deficiency were more likely to be obese and
took supplements but not vitamin D or did not take
supplements at all. Those with levels < 75 nmol/L were
more likely to be obese and take supplements but not
vitamin D. All of these participants also had blood
samples taken in winter and spring. For both males and
females, those who undertook a sufficient level of ac-
tivity were less likely to have serum 25(OH)D less than
50 nmol/L or 75 nmol/L.
Discussion
This study examined the levels of serum 25(OH)D within
the population and although large studies have been
undertaken in Australia and elsewhere (for example, Daly
et al. [23], Melamed et al. [3], Green-Finestone et al. [10]
and Brock et al. [29]), this study specifically examines a
population sample from SA, weighted to be reflective of
the state and with a wide range of covariates also mea-
sured, which allows an in depth examination of factors as-
sociated with vitamin D. Levels of vitamin D within the
population have received increased focus over recent
times due to the association of vitamin D deficiency with
not only bone health but mortality and various other con-
ditions [1-9]. As the majority of Australians obtain vitamin
D as a result of exposure to sunlight, there is also the need
to address vitamin D deficiency while ensuring that the
risk of skin cancer and the skin cancer population mes-
sages are also recognised [1].
While the mean serum 25(OH)D levels within this
population were within the optimal level recommended in
SA, 38.5% still have levels below 60 nmol/L and 22.7%
had levels below 50 nmol/L. The Australian Bureau of
Statistics National Health Measures Survey (NHMS) con-
ducted in 2011/12 also showed a similar proportion of
South Australians (26.7%) aged 18 years and over with
vitamin D levels < 50 nmol/L [30]. Additionally, there was
a higher prevalence of deficiency among women (26.8%)
compared to men (18.5%) which is similar to previous
results [23]. However, debate does continue as to the
Table 5 Prevalence of serum 25(OH)D levels < 50 and <75 nmol/l, and adjusted odds ratios in females
<50 nmol/l <75 nmol/l
Variables n Prevalence Odds ratio† n Prevalence Odds ratio†
Overall 334 26.7 861 68.9
Age (years)
24-34 years 53 21.4 1.00 167 67.3 1.00
35-44 years 69 26.9 1.28 (0.60-2.70) 189 74.1 1.48 (0.74-2.95)
45-54 years 85 34.7 1.83 (0.92-3.66) 178 72.8 1.33 (0.70-2.56)
55-64 years 50 24.8 0.96 (0.45-2.04) 135 66.5 0.88 (0.45-1.76)
65-74 years 38 26.6 1.01 (0.45-2.27) 101 71.2 1.16 (0.55-2.45)
75 years and over 40 25.3 0.88 (0.37-2.10) 91 58.0 0.70 (0.32-1.54)
BMI*
Underweight/normal 81 20.1 1.00 245 60.8 1.00
Overweight 99 24.4 1.29 (0.82-2.02) 272 67.0 1.41 (0.95-2.10)
Obese 154 35.0 1.97 (1.29-3.03) 344 78.1 2.32 (1.55-3.48)
Country of birth*
Australia 233 25.3 1.00 624 67.7 1.00
Other country 100 31.0 1.26 (0.88-1.81) 234 72.4 1.35 (0.95-1.90)
Season
Summer 48 16.1 1.00 186 63.0 1.00
Autumn 59 21.8 1.59 (0.86-2.94) 168 62.3 1.01 (0.62-1.63)
Winter 127 35.0 2.89 (1.67-5.01) 258 71.0 1.46 (0.91-2.36)
Spring 101 31.3 2.51 (1.46-4.29) 250 77.4 2.16 (1.32-3.55)
Income
Up to $60,000 173 29.5 1.00 413 70.4 1.00
More than $60,000 129 24.8 0.90 (0.58-1.41) 364 69.9 0.90 (0.57-1.43)
Don’t know/not stated 33 22.8 0.81 (0.43-1.53) 84 59.1 0.72 (0.39-1.32)
Education
Some schooling 144 28.7 1.00 341 67.9 1.00
Completed high school 44 24.0 0.82 (0.44-1.52) 129 70.3 1.03 (0.60-1.80)
Apprentice/diploma 85 27.7 1.04 (0.67-1.59) 217 71.0 1.07 (0.68-1.68)
University or higher education 52 22.7 0.92 (0.53-1.57) 156 68.1 1.20 (0.68-2.11)
Refused/not stated 9 32.2 2.59 (0.39-17.17) 17 61.4 4.11 (0.44-38.20)
Smoking status
Non/ex 278 27.1 1.00 693 67.6 1.00
Current 52 25.1 0.86 (0.51-1.43) 159 75.9 1.43 (0.84-2.45)
Not stated 4 24.5 0.61 (0.23-1.65) 9 61.1 0.69 (0.25-1.90)
Physical activity
No activity 95 37.0 1.00 193 75.4 1.00
Insufficient activity 135 30.9 0.75 (0.47-1.21) 314 71.9 0.81 (0.49-1.35)
Sufficient activity 96 18.3 0.37 (0.23-0.60) 336 63.9 0.59 (0.36-0.96)
Not stated 9 28.9 0.30 (0.05-1.79) 18 57.7 0.19 (0.02-1.60)
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Table 5 Prevalence of serum 25(OH)D levels < 50 and <75 nmol/l, and adjusted odds ratios in females (Continued)
Vitamin D supplement
Took vitamin D 6 8.3 1.00 46 60.4 1.00
Took supplements but not vitamin D 99 27.2 4.68 (2.03-10.75) 264 72.3 1.80 (1.02-3.17)
Did not take supplements/not stated 229 28.3 5.14 (2.31-11.45) 550 68.2 1.44 (0.86-2.44)
*Not stated category not reported n ≤ 10. The weighting of data can lead to rounding discrepancies and totals not adding.
†Adjusted for age group, BMI categories, country of birth, season, income, education, smoking status, activity level, vitamin D supplement status.
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authors have recommended a level of ≥ 75 nmol/L is ap-
propriate to ensure musculoskeletal health benefits [31].
In this study, approximately two thirds of participants
(64.3%) had serum 25(OH)D below this level. However,
these prevalences are below those obtained by Daly et al.
[23] and may be due to differences in serum 25(OH)D as-
says, time of the year that samples were obtained and the
population that was sampled. A prevalence of 22.7% with
serum 25(OH)D levels below 50 nmol/L is consistent with
results obtained from other Australian [18-22] and inter-
national studies [13-17], but also further highlights the im-
pact of different study populations, locations, vitamin D
intake and fortification of foods and methodology on
study result on the importance of locally relevant data in
order to determine the level of vitamin D deficiency.
Daly et al. [23] demonstrated that mean levels of 25
(OH)D (unadjusted and adjusted) decreased with age for
both males and females and that the prevalence of
deficiency generally increased with age. However in this
study, age was not significantly associated with vitamin
D deficiency and mean levels of 25(OH)D, were higher
in the older age groups. This study also examined the
use of vitamin D supplements. The non-use of vitamin
D supplements was significantly associated with 25(OH)
D deficiency among females but not males. While only a
small proportion (4.1% overall) reported using sup-
plements, use did increase across age groups with the
highest proportion of those taking vitamin D, in the
75 years and over age group, where mean levels of 25
(OH)D were also higher, perhaps demonstrating the
effectiveness of supplement use amongst the older popu-
lation in South Australia. These results compare well
with the NHMS which demonstrated that 4.3% of the
population of SA aged 18 years and over, took vitamin D
supplements in 2011/12 [32] and that use was more
common among older women [33]. However, compli-
ance and tolerance can be issues within the older popu-
lation [2] and the elderly, particularly those in residential
care have been identified as a high-risk group for
vitamin D deficiency [34]. These findings highlight that
taking vitamin D may be effective in achieving higher
mean levels and reducing vitamin D deficiency but im-
proved recommendations relating to supplementation
may be required in order to increase the rate of uptake.Also of note is the issue of assay technique, which can
exhibit variations. There has also been a recent increase
in the number of tests for 25(OH)D, thus traditional test
procedures have been discarded for tests that are more
prone to interference [35]. Both of the foci described
above align well with quality use of medicines and diag-
nostic testing messages.
The effect of seasonality on 25(OH)D levels is highlighted
in this study. Both adjusted and unadjusted mean values
of serum 25(OH)D were lower in winter and spring as
were the adjusted and unadjusted prevalences of defi-
ciency. Participants with samples taken in both winter and
spring were more likely to have vitamin D levels less than
50 and 75 nnmol/L. These findings support previous
results [1,10,23,25] and highlight that season is a major
factor in determining vitamin D levels. Latitude has also
been shown to be consideration associated with lower
levels of serum 25(OH)D in Australia [22,23] and while
the combination of these two factors only accounted for
approximately one fifth of the variation in vitamin D levels
[22] it may be that a more active vitamin D supplementa-
tion program aimed at increasing the number of people
taking supplements needs to occur, in winter and spring.
Mean vitamin D levels were generally higher among
those with lower education levels, which may reflect occu-
pational choices and similarly to Daly et al. [23], males
with higher education levels were more likely to have 25
(OH)D levels less than 50 nmol/L, whereas females were
not. This may reflect age, supplement use and occupa-
tional influences among both males and females. Country
of birth also influenced vitamin D levels with males not
born in Australia more likely to be vitamin D deficient.
Ethnicity has previously also been shown to be a factor as-
sociated with lower levels of vitamin D [10,23] and has
been linked to darker skin, time spent outdoors and clo-
thing particularly among females [1,10,23]. In this study,
while males not born in Australia were more likely to have
vitamin D levels < 50 nmol/L, the effect was of country of
birth was not as marked for females.
This study identified that low levels of physical activity
were associated with low levels of serum 25(OH)D; those
with higher levels of physical activity were less likely to
have vitamin D levels below 50 or 75 nmol/L. This is in
line with the findings of Daly et al. [23] and Brock et al.
[29], who demonstrated that vigorous activity was a
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http://www.biomedcentral.com/1471-2458/14/1001predictor of vitamin D status. Generally it is considered
that high levels of activity are a surrogate measure of sun
exposure, however it remains unclear whether exercise it-
self may contribute to vitamin D status [29]. High levels of
BMI were also associated with low vitamin D levels with
both males and females classified as obese more likely to
be vitamin D deficient. Those who are obese may tend to
undertake less activity, however this inverse relationship
has also been attributed to cholecalciferol, the precursor
to vitamin D being trapped in adipose tissue and thus the
contribution to whole body vitamin D status is minimized
as conversion to 25(OH)D does not occur [29].
This study demonstrated that non and ex-smokers had
higher mean levels of serum 25(OH)D compared to
current smokers for both males and females, as has been
shown in previous studies [23,36] however current male
smokers were not significantly more likely to be vitamin D
deficient and current female smokers had a lower preva-
lence of serum 25(OH)D less than 50 nmol/L compared
to non-smokers possibly as a result of requirements to
smoke outdoors in some environments. Gender, obesity,
season, activity levels and vitamin D supplementation all
appear to have a stronger association with vitamin D defi-
ciency in this cohort than smoking status.
The strengths of this study are the large sample size of
over 2000 blood samples which were available to be
tested for serum 25(OH)D and the range of behavioral
measurements obtained as part of the NWAHS. Weight-
ing of the data ensures that the results are representative
of the population from which the original sample was
randomly selected. Limitations include the self-reporting
of health risk factors such as smoking and physical ac-
tivity, the small number of participants born in countries
other than Australia and the use of country of birth as
an indicator of ethnicity and the non-measurement of
factors such as parathyroid hormone and bone res-
portion markers which would enable a greater under-
standing of the role of 25(OH)D in relation to bone and
mineral homeostasis in this cohort. Information relating
to the use of sunscreen and the time spent outdoors was
also not collected, however both of these factors may
also impact vitamin D levels. Australia has, however, a
high rate of melanoma compared with other countries
and there has been a focus on skin cancer prevention ac-
tivities with a resultant increase in sun protection beha-
viours which may impact on the prevalence of vitamin D
deficiency [37]. The use of foods fortified with vitamin D
was also not specifically examined.
Conclusions
In conclusion, vitamin D levels below 50 nmol/L are pre-
valent in the South Australian population, and given the
burden of conditions related to low levels of vitamin D,
represent a significant public health issue. Targeting ofphysical activity and reduction in obesity may assist in
improving vitamin D levels. The use of supplementation
remains an issue at a population level and in line with a
quality use of medicines approach [38] consideration
should be given to alternative methods of supplementa-
tion provision in order to improve serum 25(OH)D levels.
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